Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9875540rdf:typepubmed:Citationlld:pubmed
pubmed-article:9875540lifeskim:mentionsumls-concept:C0002395lld:lifeskim
pubmed-article:9875540lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:9875540lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:9875540lifeskim:mentionsumls-concept:C0993609lld:lifeskim
pubmed-article:9875540pubmed:issue2lld:pubmed
pubmed-article:9875540pubmed:dateCreated1999-3-11lld:pubmed
pubmed-article:9875540pubmed:abstractTextThe Gallyas-Braak silver impregnation method revealed neurons containing well-defined intraneuronal granules in both Alzheimer's disease and normal control brains. The granules were immunostained prominently with the Alz-50 antibody and, to a lesser degree, with the tau-2 antibody, but not with other anti-tau antibodies examined. The areas of distribution of granule-containing neurons detected by the Gallyas-Braak method appeared to overlap with the reported main sites of subcortical distribution of neurofibrillary tangles. They, however, were not observed in the cerebral cortex, including the hippocampal region. The Alz-50 immunoreactive granules showed ultrastructural features similar to those of lysosomes or lipofuscin. These findings suggest that denatured tau might be degraded in lysosomes.lld:pubmed
pubmed-article:9875540pubmed:languageenglld:pubmed
pubmed-article:9875540pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875540pubmed:citationSubsetIMlld:pubmed
pubmed-article:9875540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875540pubmed:statusMEDLINElld:pubmed
pubmed-article:9875540pubmed:monthDeclld:pubmed
pubmed-article:9875540pubmed:issn0304-3940lld:pubmed
pubmed-article:9875540pubmed:authorpubmed-author:TsuchiyaKKlld:pubmed
pubmed-article:9875540pubmed:authorpubmed-author:IkedaKKlld:pubmed
pubmed-article:9875540pubmed:authorpubmed-author:KondoHHlld:pubmed
pubmed-article:9875540pubmed:authorpubmed-author:AraiTTlld:pubmed
pubmed-article:9875540pubmed:authorpubmed-author:AkiyamaHHlld:pubmed
pubmed-article:9875540pubmed:authorpubmed-author:HageGGlld:pubmed
pubmed-article:9875540pubmed:authorpubmed-author:IritaniSSlld:pubmed
pubmed-article:9875540pubmed:issnTypePrintlld:pubmed
pubmed-article:9875540pubmed:day18lld:pubmed
pubmed-article:9875540pubmed:volume258lld:pubmed
pubmed-article:9875540pubmed:ownerNLMlld:pubmed
pubmed-article:9875540pubmed:authorsCompleteYlld:pubmed
pubmed-article:9875540pubmed:pagination113-6lld:pubmed
pubmed-article:9875540pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:meshHeadingpubmed-meshheading:9875540-...lld:pubmed
pubmed-article:9875540pubmed:year1998lld:pubmed
pubmed-article:9875540pubmed:articleTitleAlz-50/Gallyas-positive lysosome-like intraneuronal granules in Alzheimer's disease and control brains.lld:pubmed
pubmed-article:9875540pubmed:affiliationDepartment of Neuropathology, Tokyo Institute of Psychiatry, Japan. kenikeda@prit.go.jplld:pubmed
pubmed-article:9875540pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9875540pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9875540lld:pubmed